The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ardisianone ID: ALA4552664
Cas Number: 66398-68-3
PubChem CID: 442721
Max Phase: Preclinical
Molecular Formula: C24H38O5
Molecular Weight: 406.56
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCCCC(CC1=CC(=O)C=C(OC)C1=O)OC(C)=O
Standard InChI: InChI=1S/C24H38O5/c1-4-5-6-7-8-9-10-11-12-13-14-15-22(29-19(2)25)17-20-16-21(26)18-23(28-3)24(20)27/h16,18,22H,4-15,17H2,1-3H3
Standard InChI Key: CVZNKLNAHBTINT-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 29 0 0 0 0 0 0 0 0999 V2000
2.2411 -2.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2411 -3.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9505 -3.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6599 -3.5742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6599 -2.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9505 -2.3360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5281 -2.3422 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5257 -1.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9505 -1.5147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9505 -4.8000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3729 -2.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0836 -2.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7925 -2.3464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0812 -3.5783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7877 -3.9890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7853 -4.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5007 -3.5825 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5031 -2.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2161 -2.3505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9268 -2.7653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9244 -3.5866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6350 -3.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6326 -4.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3432 -5.2334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3409 -6.0547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6278 -6.4612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9172 -6.0506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2042 -6.4571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4935 -6.0464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
1 7 1 0
7 8 1 0
6 9 2 0
3 10 2 0
5 11 1 0
11 12 1 0
12 13 1 0
12 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
13 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.56Molecular Weight (Monoisotopic): 406.2719AlogP: 5.62#Rotatable Bonds: 16Polar Surface Area: 69.67Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 6.29CX LogD: 6.29Aromatic Rings: ┄Heavy Atoms: 29QED Weighted: 0.19Np Likeness Score: 1.69
References 1. Xu X, Meng Y, Li L, Xu P, Wang J, Li Z, Bian J.. (2019) Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions., 62 (3): [PMID:30148361 ] [10.1021/acs.jmedchem.8b00961 ]